LEDBURY HEALTH PARTNERSHIP
LEDBURY MARKET P/SHIP, MARKET STREET, LEDBURY
HF 4
The percentage of patients with a current diagnosis of heart failure due to LVD who are currently treated with an ACE inhibitor or Angiotensin Receptor Blocker, who are additionally treated with a beta-blocker licensed for heart failure, or recorded as intolerant to or having a contraindication to beta-blockers.
| Indicator | Year | Numerator | Denominator | Ratio | Centile |
|---|---|---|---|---|---|
| HF 4 | 2010 | 45 | 50 | 90.0% | |
| HF 4 | 2011 | 42 | 51 | 82.4% | |
| HF 4 | 2012 | 39 | 47 | 83.0% | |
| HF 4 | 2013 | 37 | 44 | 84.1% | |
| HF004 | 2014 | 2 | 2 | 100.0% | |
| HF004 | 2015 | 3 | 3 | 100.0% | |
| HF004 | 2016 | 4 | 4 | 100.0% | |
| HF004 | 2017 | 52 | 58 | 89.7% | |
| HF004 | 2018 | 49 | 50 | 98.0% | |
| HF004 | 2019 | 61 | 65 | 93.8% | |
| HF004 | 2020 | 41 | 48 | 85.4% | |
| HF006 | 2021 | 50 | 62 | 80.6% | |
| HF006 | 2022 | 71 | 71 | 100.0% | |
| HF006 | 2023 | 79 | 84 | 94.0% |
